EV Biologics Inc (YECO)
0.5741
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
EV Biologics Shareholders Equity (Quarterly): 2.930M for Dec. 31, 2017
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2017 | 2.930M |
| December 31, 2016 | 6.026M |
| September 30, 2016 | 8.576M |
| June 30, 2016 | 11.26M |
| March 31, 2016 | 72.91M |
| December 31, 2015 | 69.45M |
| Date | Value |
|---|---|
| September 30, 2015 | 68.74M |
| June 30, 2015 | 46.65M |
| March 31, 2015 | 44.09M |
| December 31, 2014 | 41.85M |
| September 30, 2014 | 40.00M |
| June 30, 2014 | 37.65M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.82M |
| Total Liabilities (Quarterly) | 28.89M |